As the studys authors put it, treatment decisions for obesity should be individualised weighed against harms, cost, tolerability and what the patient actually wants, not settled by whichever number is loudest on the label
The following is a breakdown of it: Type and stage of fatty liver Simple Fatty Liver (NAFLD): Typically costs less to treat with lifestyle interventions, lab tests and follow-ups fewer tests needed Fibrosis or Cirrhosis or NASH (Non-alcoholic steatohepatitis): Liver biopsy, advanced imaging or medications are often needed businesses have higher costs AFLD (Alcoholic fatty liver disease): Includes alcohol de-addiction support, further counselling and, potentially, hospitalization Tests necessary to provide Diagnosis The cost can be dramatically affected by initial and follow-up tests: LFT (Liver Function Test) Ultrasound Abdomen Elastography (advanced test): FibroScan or MRI (advanced tests) HbA1c, blood sugar, lipid profile Liver biopsy (in case required) Medication & Supplements Simplified cocktail: Vitamin E, Fatty acids Omega-3, antidiabetic drugs Moderate management: Pioglitazone, GLP-1, statins, insulin (when sufferer is diabetic) Lifestyle support & Dietary Fitness/Wellness programs: These could be fitness/yoga programs tailored to the individual which would be extra expenditure Kind of Healthcare Facility Private hospitals/clinics: More expensive consultations, laboratory and monitoring Corporate hospitals or liver specialty centers (e.g
doi: 10.1016/j.arr.2020.101249 198 GibbAALazaropoulosMPElrodJW
For lunches or dinners, I often turn to simple protein sources like eggs or beans and legumes
The Bridge program currently covers specific GLP-1 medications that hold FDA approval for weight loss
That's where 1st Phorm Supplements come in
